Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
| Descriptor ID |
D003271
|
| MeSH Number(s) |
D27.505.696.875.360.276 D27.505.954.705.360.276
|
| Concept/Terms |
Contraceptive Agents, Female- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
|
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in this website by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 3 | 0 | 3 |
| 2016 | 3 | 1 | 4 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
-
Development of a Peer-Based Intervention Educating Teenagers about Long-Acting Reversible Contraception. J Pediatr Adolesc Gynecol. 2023 Aug; 36(4):406-412.
-
Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC). Contraception. 2022 08; 112:11-13.
-
Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding. J Pediatr Adolesc Gynecol. 2021 Aug; 34(4):514-521.
-
Reasons Why Young Women in the United States Choose Their Contraceptive Method. J Womens Health (Larchmt). 2021 01; 30(1):64-72.
-
Association of Immediate Postpartum Etonogestrel Implant Insertion and Venous Thromboembolism. Obstet Gynecol. 2020 06; 135(6):1275-1280.
-
Intrauterine Devices: Effective Contraception with Noncontraceptive Benefits for Adolescents. J Pediatr Adolesc Gynecol. 2019 Sep; 32(5S):S2-S6.
-
Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial. Contraception. 2018 09; 98(3):193-198.
-
Increased 1-year continuation of DMPA among women randomized to self-administration: results from a randomized controlled trial at Planned Parenthood. Contraception. 2018 03; 97(3):198-204.
-
Differences in Women Who Choose Subdermal Implants Versus Intrauterine Devices. J Reprod Med. 2016 Nov-Dec; 61(11-12):529-33.
-
Levonorgestrel-Releasing Intrauterine Device Use in Female Adolescents with Heavy Menstrual Bleeding and Bleeding Disorders: Single Institution Review. J Pediatr Adolesc Gynecol. 2017 Aug; 30(4):479-483.